Spain· ES:11694002
NULOJIX 250 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
A medicinal product containing belatacept, registered in Spain by Bristol-Myers Squibb Pharma Eeig.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- belatacept
- Manufacturer
- Bristol-Myers Squibb Pharma Eeig
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Belatacept in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNULOJIXBristol-Myers Squibb Pharma EEIG, Dublin
- FinlandNulojixBristol-Myers Squibb Pharma EEIG
- United KingdomNulojix 250mg powder for concentrate for solution for infusion vialsBristol-Myers Squibb Pharmaceuticals Ltd
- IrelandNULOJIX 250 mg powder for concentrate for solution for infusionBristol-Myers Squibb Pharma EEIG
- IcelandNulojixBristol-Myers Squibb Pharma EEIG*
- NorwayNulojixBristol-Myers Squibb Pharma EEIG
- PolandNulojixBristol-Myers Squibb Pharma EEIG
- BelgiumNulojix 250 mgBristol-Myers Squibb Pharma
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Nulojix
- Liechtenstein · Nulojix
- Norway · Nulojix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2a0af9ef-2b16-4590-9a3b-1680d8950a26 GET /v1/drugs/2a0af9ef-2b16-4590-9a3b-1680d8950a26?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1312236000000}",
"nregistro": "11694002",
"substance": "belatacept"
}See everything about belatacept.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.